Daniela M. Ferreira

University of Liverpool - School of Tropical Medicine

SCHOLARLY PAPERS

5

DOWNLOADS
Rank 335

SSRN RANKINGS

Top 335

in Total Papers Downloads

88,695

SSRN CITATIONS

3

CROSSREF CITATIONS

2

Scholarly Papers (5)

1.

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Number of pages: 37 Posted: 01 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Siena - Institute of Global Health, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, Federal University of São Paulo (UNIFESP), University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand, Stellenbosch University - Family Centre for Research with Ubuntu, Soweto Clinical Trials Centre, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Oxford Vaccine Group, GSK plc, University of Oxford - The Jenner Institute, Wits Reproductive Health & HIV Institute (WRHI), University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Oxford - Oxford Vaccine Group, University of Liverpool - School of Tropical Medicine, University of Bristol - Bristol Vaccine Centre, St George’s University London - St George’s Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, Liverpool School of Tropical Medicine - Department of Clinical Sciences, AstraZeneca Pharmaceuticals, University of the Witwatersrand - South African Medical Research Council, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand - South African Medical Research Council, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Oxford - Centre for Vaccinology and Tropical Medicine, AstraZeneca Pharmaceuticals, Braziland Hospital São Rafael - Escola Bahiana de Medicina e Saúde Pública, Universidade Federal do Rio Grande do Norte (UFRN), University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - Perinatal HIV Research Unit, Setshaba Research Centre, University of Oxford - Oxford Vaccine Group, Hospital Quinta D'OR, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Hospital Universitário de Santa Maria, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Universidade Federal do Rio Grande do Sul, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, University of Cambridge - Department of Medicine, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group and Independent
Downloads 52,357 (50)
Citation 3

Abstract:

Loading...

2.

Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine

Number of pages: 45 Posted: 25 Jun 2021
University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Public Health England Colindale, Government of the United Kingdom - Public Health Scotland, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Liverpool - School of Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University Hospitals Birmingham NHS Foundation Trust, Public Health England - National Infection Service, University of London - Institute of Infection and Immunity, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Bristol - Bristol Vaccine Centre, University of Oxford - The Jenner Institute, Government of the United Kingdom - North Bristol NHS Trust, NIHR UCLH Clinical Research Facility, Public Health England - Immunisation, Hepatitis, and Blood Safety Department, University of Southampton - University Hospital Southampton NHS Foundation Trust, Nottingham University Hospitals NHS Trust, Imperial College London - National Heart & Lung Institute, University of Nottingham - Division of Epidemiology and Public Health, University of Oxford - Centre for Vaccinology and Tropical Medicine and Independent
Downloads 25,273 (202)
Citation 6

Abstract:

Loading...

3.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Number of pages: 40 Posted: 04 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Oxford - Big Data Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge - Department of Medicine, University of Oxford - Big Data Institute, University of Oxford - The Jenner Institute, Public Health England - National Infection Service, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, UK Biocentre, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, GSK plc, University of Oxford - The Jenner Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Liverpool - School of Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Bristol - Bristol Vaccine Centre, University of Oxford - The Jenner Institute, University of Oxford - Jenner Institute, St George’s University London - St George’s Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, Public Health England - National Infection Service, University of London - Institute of Infection and Immunity, Queen Elizabeth University Hospital, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, Genomics England, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Independent and Independent
Downloads 10,963 (907)
Citation 26

Abstract:

Loading...

4.

Household Air Pollution (HAP) is Associated With Increased Pneumococcal Carriage in Malawian Infants – Malawi  Streptococcus pneumoniae Carriage and Air Pollution Exposure (MSCAPE) Study

Number of pages: 19 Posted: 19 Mar 2021
University of Liverpool, University of Liverpool - Department of Public Health, Policy and Systems, Malawi Epidemiology and Intervention Research Unit (MEIRU), University of Liverpool, Research Triangle Institute (RTI) International, University of Malawi - College of Medicine, Malawi Epidemiology and Intervention Research Unit (MEIRU), Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, University of Liverpool - School of Tropical Medicine, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, St George’s University London - Institute for Infection and Immunity, Liverpool School of Tropical Medicine - Department of Clinical Sciences, Liverpool School of Tropical Medicine, University of Liverpool and University of Liverpool
Downloads 54 (690,582)

Abstract:

Loading...

5.

Randomised Controlled Trial of Pneumococcal Conjugate Vaccine Shows Protection Against Experimental Pneumococcal Carriage in First Human Infection Study in Africa

Number of pages: 30 Posted: 15 Dec 2022
University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Liverpool - School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Kamuzu University of Health Sciences, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, University of Liverpool - School of Tropical Medicine, University of Liverpool - School of Tropical Medicine, University of Liverpool - School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme and University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Downloads 48 (727,550)

Abstract:

Loading...

Streptococcus pneumoniae, controlled Human infection Model, Pneumococcal carriage, Nasal, Mucosal inflammation, Malawi